As shown in Figure 2, we found that monocytes of untreated sHLH/MAS patients showed a significant increase in responsiveness to IFNγ stimulation (at 1 and 10 ng/ml of IFNγ), compared to all the other disease control groups. The gene discussed is IFNG; the disease is macrophage activation syndrome.